USC Dornsife News

Using nano-probes to amplify biochemical signals could lead to targeted, noninvasive treatment of cancer.

USC Dornsife’s Mark Thompson co-delivers a keynote address at the recent inaugural UCLA-USC-Caltech symposium. Thompson discusses his pioneering tiny indium oxide devices that can detect the presence of a protein in the blood of ovarian cancer patients.

Nanoscale spectrometer helps USC College biologists describe a missing step in the global carbon and nitrogen process.